The larger Nobel Biocare Global Symposia event series will span from 2019 to 2021 and take place in Europe, North America and Asia.
The originally scheduled Global Symposium will still take place in June of 2019, however, instead of the previously announced, Las Vegas, the first stop will be changed to Europe where the initial wave of game-changing solutions from Nobel Biocare will be available first.
The Global Symposium in Las Vegas will be held in April 2020, followed by another Global Symposium in Asia during 2021.
The enhanced event strategy follows the tremendously positive feedback received from clinicians involved in the early stages of the groundbreaking solutions to come. Having a full series of global symposia provides an optimal platform to effectively reach and train dental professionals around the world.
Participants at the symposia will be the first in their regions to discover original solutions ranging from redefined surface science, revolutionary implant design and site-preparation techniques to implant care and digital solutions designed to further enhance the patient treatment journey. The new innovations will be onsite for attendees to experience through in-depth demonstrations as well as new state-of-the-art training and educational activities.
Hans Geiselhöringer, President of Nobel Biocare said: “A larger Nobel Biocare Global Symposia event series will help us better leverage the enthusiasm and anticipation already being generated around our upcoming new breakthrough innovations. With exciting new symposia to be held in Europe, North America and Asia, more dental professionals than ever will be able to take part in what will mark a real turning point in implant treatment care.”
Dates and locations for the event series will be available soon. New information about the Global Symposium event series will be available at www.nobelbiocare.com/events.
Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company’s portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive®, Brånemark System® and NobelReplace®), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), diagnostics, treatment planning and guided surgery solutions (NobelClinician® and DTX Studio™) and biomaterials (creos™). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland. Production takes place at six sites located in the United States, Sweden, Japan and Israel. Products and services are available in over 80 countries through subsidiaries and distributors.